Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXK9FD
|
||||
| Drug Name |
2-((4-(5-fluoro-1H-indol-3-yl)-5,6-dihydropyridin-1(2H)-yl)methyl)-8-methoxy-4-propyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
||||
| Synonyms |
CHEMBL382333
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30FN3O2
|
||||
| Canonical SMILES |
CCCN1CC(CN2CCC(=CC2)c3c[nH]c4ccc(F)cc34)Oc5c(OC)cccc15
|
||||
| InChI |
InChI=1S/C26H30FN3O2/c1-3-11-30-17-20(32-26-24(30)5-4-6-25(26)31-2)16-29-12-9-18(10-13-29)22-15-28-23-8-7-19(27)14-21(22)23/h4-9,14-15,20,28H,3,10-13,16-17H2,1-2H3
|
||||
| InChIKey |
KBGIAHKLLKPEIS-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.